Exosome Diagnostics Announces Publication of a Highly Sensitive Exosome Based Liquid Biopsy Test for EGFR T790M Mutations in Plasma from Non-Small Cell Lung Cancer Patients
Benzinga,
(GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, recently…